Navigation Links
Cancer risk raised after northern Italian industrial accident
Date:9/14/2009

People living in the Seveso area of Italy, which was exposed to dioxin after an industrial accident in 1976, have experienced an increased risk of developing cancer. Researchers writing in BioMed Central's open access journal Environmental Health found an increased risk of breast cancer in women from the most exposed zone and an excess of lymphatic and hematopoietic tissue neoplasms in all but the least exposed zone.

Angela Pesatori led a team of researchers from the Fondazione IRCCS Ospedale Maggiore Policlinico, a local hospital associated with the University of Milan, who extended a study of cancer incidence in the area, which now covers the period 1977-96. She said, "The industrial accident that occurred in the Seveso area in 1976 exposed a large residential population to substantial amounts of TCDD [2,3,7,8-tetrachlorodibenzo-p-dioxin]. Although the International Agency for Research on Cancer and the US Environmental Protection Agency have both classified TCDD as human carcinogen, scientific debate still persists on the actual cancer risk posed to the general population. We've found that it does pose a carcinogenic hazard, although lower than anticipated from animal studies, at least at the levels experienced by this population after this accident".

The researchers studied the medical records of all subjects living in the area at the date of the accident (July 10, 1976) and those who migrated into, or were born in, the area during the following 10 years. Of these 36,589 files, 99.9% were successfully reviewed. There were 2122 cases of cancer, 660 of which occurred after 1991. Specific and significant increases in risk, compared to the general population, were discovered for breast cancer and lymphatic and hematopoietic neoplasms, although based on a small number of cases. Speaking about these results, Pesatori said, "These increases were expected based on previous studies. The mortality study, which covered a longer follow-up period, confirmed the excess of lymphatic and hematopoietic risk. We did not identify an all-cancer excess, as seen in occupational cohorts which had similar, sometimes higher, and more complex exposures".


'/>"/>

Contact: Graeme Baldwin
graeme.baldwin@biomedcentral.com
44-203-192-2165
BioMed Central
Source:Eurekalert

Related medicine news :

1. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
2. Survival differences by race most apparent in advanced stages of breast cancer
3. MRI finds breast cancer before it becomes dangerous
4. Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer
5. Pathway links inflammation, angiogenesis and breast cancer
6. Radiologists encouraged to look beyond cancer for clinically unseen diseases
7. Diet high in meat, fat and refined grains linked to risk for colon cancer recurrence, death
8. Immune deficiency linked to a type of eye cancer
9. Drop in breast cancer incidence linked to hormone use, not mammograms
10. Breast cancer prevention practices vary across Canada
11. First biomarker discovered that predicts prostate cancer outcome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... will be giving viewers the lowdown on sciatica in a new episode of ... that focuses on current events and innovation and investigates each subject in-depth with ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the ... “America On The Brink” is the creation of published author, William Nowers. Captain ... As a WWII veteran, he spent thirty years in the Navy. Following his ...
(Date:10/12/2017)... LA (PRWEB) , ... October 12, 2017 , ... Planet ... in the U.S., announced today its plans to open a flagship location in Covington, ... occupy the former Rooms To Go store next to Office Depot in the Holiday ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical Informatics (ACMI) ... FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s ... Morris F. Collen, a pioneer in the field of medical informatics, this prestigious award ...
(Date:10/12/2017)... ... 2017 , ... Dr. Parsa Mohebi, the Los Angeles based ... the newly revamped Cosmetic Town journal section, featuring articles written by ... as Follicular Unit Extraction (FUE). , Dr. Mohebi says “I enjoy ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... Janssen Biotech, Inc. (Janssen) announced today that ... U.S. Food and Drug Administration (FDA) for the Biologics ... treatment of moderately to severely active rheumatoid arthritis (RA). ... needed to further evaluate the safety of sirukumab in ... "We are disappointed ...
(Date:9/19/2017)... , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing ... of targeted tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek ...
(Date:9/18/2017)... PROVIDENCE, R.I. , Sept. 18, 2017 ... in the fields of bioinformatics and immune ... to develop a protective avian influenza A (H7N9) vaccine. ... is distantly related to seasonal influenza and ... approaches, which rely on prior exposure to be ...
Breaking Medicine Technology: